Sumitomo Mitsui Trust Holdings, Inc. Corcept Therapeutics Inc Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	BUY	$17.33 - $25.3 $208,081 - $303,777	12,007 New	12,007 $286,000
Q3 2020 Oct 30, 2020	SELL	$12.46 - $19.98 $257,286 - $412,567	-20,649 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$11.0 - $18.26 $227,139 - $377,050	20,649 New	20,649 $347,000

361

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.